RxDoctor Payments Data

Lora Brown, APRN

Family · Monticellow, KYNPI 1699135723

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $50,140 of the $60,870 with a category attached, or 82.4%. Novo Nordisk accounts for 96.4% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $20,545 and has fallen 78.1% since, to $4,495 in 2025. Among family clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,870in general payments, 2019–2025

Across 252 payments — averaging $241.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$59K
  • Paratek Pharmaceuticals, Inc.$996
  • Lilly USA, LLC$180
  • Teva Pharmaceuticals USA, Inc.$154
  • Biohaven Pharmaceutical Holding Company Ltd.$142
  • Sanofi-aventis U.S. LLC$140
  • plus $589 from 16 others

What the payments were for

  • Consulting fees$8001%
  • Speaking & faculty fees$50,14082%
  • Travel & lodging$5,6609%
  • Food & beverage$4,2587%
  • Education$120%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,870 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$18,660
Medicare patients
146
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate23$533
Doxycycline Hyclate74$433
Cefdinir21$287
Azithromycin77$282
Dexamethasone38$234
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$213
Nystatin12$168
Metoclopramide Hcl14$144
Lisinopril21$136
Fluticasone Propionate19$129
Pantoprazole Sodium20$124
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$95
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$91
Mupirocin13$81
Fluconazole11$72

Paid to pharmacies, not to this prescriber.

Other family in Monticellow

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →